Interviews

Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

73280 1529934376HCLSReviewMedicalCannabisinCanadaJune2018.pdf
Energy Boardroom

Pharma Interviews


Filter

Interview: Lucas Sigman – Director General, Chemo, Spain

Lucas Sigman, director general of Chemo, a leader in the research, development and manufacture of finished dosage forms and the active pharmaceutical ingredient arm of Insud Pharma, highlights the 40 years of expertise of the company in manufacturing for generic …

22.06.2018

Interview: Fanny Law Fan Chiu-fun – Chairperson, HKSTP, Hong Kong

The Hon. Fanny Law Fan Chiu-fun, chairperson, and Prof. Daniel Lee, head of the Biomedical Technology Cluster, at Hong Kong Science and Technology Parks Corporation (HKSTP) provide an update on Hong Kong’s biotech scene, government commitment to innovation, and Hong Kong’s …

21.06.2018


Interview: Carlos Mateos – CEO, COM Salud, Spain

Carlos Mateos, founder and CEO of Spanish digital healthcare PR specialist, COM Salud, discusses opportunities for the healthcare sector in eHealth and big data as well as the benefits that holding eHealth congresses in Spain can bring to the entire …

20.06.2018

Interview: Filipe Paias – General Manager, Baxter Portugal

Filipe Paias, general manager for Baxter International Portugal, illustrates the organizational change Baxter has undergone in the past three years, in both process, strategy, and reputation. In Portugal, Baxter is the market leader in several therapeutic areas, and Paias outlines …

20.06.2018


Interview: Stewart Pearce – Managing Director, Otsuka UK and Ireland

Stewart Pearce, managing director of Otsuka UK and Ireland since 2017 discloses how he built up a leadership team fit for the Otsuka of 2023 and highlights what he appreciates about working for a Japanese pharmaceutical company. He says that …

20.06.2018

Interview: João Goncalves – Secretary General, APORMED, Portugal

Secretary General João Goncalves of the Portuguese Trade Association for Medical Devices Companies (APORMED) – Portugal’s medtech association – welcomes readers to explore relevant trades in the medical devices segment. Although initially an association dominated by domestic players and now …

18.06.2018


Interview: Ángel Navarro – President, Azierta, Spain

Dr. Ángel Navarro, president of Azierta discusses how the company’s strategy of linking science and business has created a consultancy space through which to offer a wide range of healthcare-related services to the worldwide science environment. Additionally, he emphasizes the …

18.06.2018

Interview: Eduardo Lopez-Puertas – Managing Director, IFEMA, Spain

Eduardo Lopez-Puertas, managing director of IFEMA, Spain’s largest and most successful congress center, discusses the country’s competitive advantages compared to the rest of Europe, and the role the pharmaceutical sector plays in their strategy to contribute to Spain’s economy. Can …

18.06.2018


Interview: José Manuel Rigueiro – General Manager, Actelion Spain

Jose Manuel Rigueiro, general manager of the Spanish affiliate of Actelion, discusses the lack of trust between health authorities and the industry and the challenges of launching new orphan drugs in such a fragmented healthcare system. He highlights the successful …

18.06.2018

Interview: Nelson Pires – General Manager, Jaba Recordati Portugal, UK and Ireland

Nelson Pires provides an insightful update on Portugual’s pharmaceutical market evolution as well as Jaba Recordati’s ambitious Portuguese affiliate. Pires shares that diversification is one technique of navigating the market, introduces their expansion into a new therapeutic area, and explains …

18.06.2018


Interview: Rui Ferreira Dos Santos – Country Manager, Almirall, Portugal

Rui Ferreira Dos Santos, country manager for Spanish pharmaceutical company, Almirall provides readers with an update on the company’s new medicines and how their global strategy to become dermatology specialists manifests itself in Portugal. Rui also sheds light on the …

15.06.2018

Interview: Sheng Sitong – Founder and CEO, Considerin Group, China

Sheng Sitong, founder and CEO of gene sequencing device company, Considerin Group (formerly HYK Gene), discusses Considerin’s rapid expansion and the development of precision medicine in China. Mr. Sheng, could you briefly introduce your company, Considerin Group, to our international …

15.06.2018


LATEST ISSUE

DOWNLOAD

Most Read

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: